Evaluation and management of laryngopharyngeal reflux disease: state of the art review
Objective To review the current literature about the epidemiology, clinical presentation,
diagnosis, and treatment of laryngopharyngeal reflux (LPR). Data Sources PubMed …
diagnosis, and treatment of laryngopharyngeal reflux (LPR). Data Sources PubMed …
Time trends of gastroesophageal reflux disease: a systematic review
HB El–Serag - Clinical Gastroenterology and Hepatology, 2007 - Elsevier
There is a perception that the prevalence of gastroesophageal reflux disease (GERD) is
increasing, but few studies have directly tackled this issue. By using a systematic approach …
increasing, but few studies have directly tackled this issue. By using a systematic approach …
[HTML][HTML] National ambulatory medical care survey: 2003 summary
E Hing, DK Cherry, DA Woodwell - 2005 - stacks.cdc.gov
Objective—This report describes ambulatory care visits made to physician offices in the
United States. Statistics are presented on selected characteristics of the physician's practice …
United States. Statistics are presented on selected characteristics of the physician's practice …
[HTML][HTML] Laryngopharyngeal reflux: diagnosis, treatment, and latest research
AM Campagnolo, J Priston, RH Thoen… - International archives …, 2014 - SciELO Brasil
Introduction Laryngopharyngeal reflux (LPR) is a highly prevalent disease and commonly
encountered in the otolaryngologist's office. Objective To review the literature on the …
encountered in the otolaryngologist's office. Objective To review the literature on the …
Low-acid diet for recalcitrant laryngopharyngeal reflux: therapeutic benefits and their implications
JA Koufman - Annals of otology, rhinology & Laryngology, 2011 - journals.sagepub.com
Objectives: Laryngopharyngeal reflux (LPR) is an expensive, high-prevalence disease with
a high rate of medical treatment failure. In the past, it was mistakenly believed that pepsin …
a high rate of medical treatment failure. In the past, it was mistakenly believed that pepsin …
Direct health care costs of laryngeal diseases and disorders
Abstract Objectives/Hypothesis: To estimate the annual direct costs associated with the
diagnosis and management of laryngeal disorders. Study Design: Retrospective analysis of …
diagnosis and management of laryngeal disorders. Study Design: Retrospective analysis of …
Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux
O Reichel, H Dressel… - … –Head and Neck …, 2008 - journals.sagepub.com
OBJECTIVE: To determine the efficacy of proton pump inhibitor (PPI) therapy with
esomeprazole on symptoms and signs associated with laryngopharyngeal reflux (LPR) …
esomeprazole on symptoms and signs associated with laryngopharyngeal reflux (LPR) …
Potential benefits of pH 8.8 alkaline drinking water as an adjunct in the treatment of reflux disease
JA Koufman, N Johnston - Annals of Otology, Rhinology & …, 2012 - journals.sagepub.com
Objectives: At the cellular level, tissue-bound pepsin is fundamental to the pathophysiologic
mechanism of reflux disease, and although the thresholds for laryngeal damage in …
mechanism of reflux disease, and although the thresholds for laryngeal damage in …
Rationale for targeting pepsin in the treatment of reflux disease
N Johnston, CW Wells, TL Samuels… - Annals of Otology …, 2010 - journals.sagepub.com
Objectives: We undertook to 1) obtain unequivocal evidence to confirm or rebut our initial
observations that pepsin is taken up by hypopharyngeal epithelial cells by receptor …
observations that pepsin is taken up by hypopharyngeal epithelial cells by receptor …
A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux
C Wei - European Archives of Oto-Rhino-Laryngology, 2016 - Springer
We aimed to systematically review the randomized controlled trials (RCTs) regarding the
therapeutic efficiency of proton pump inhibitor (PPI) therapy for laryngopharyngeal reflux …
therapeutic efficiency of proton pump inhibitor (PPI) therapy for laryngopharyngeal reflux …